Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies

Anticancer Research

Volumn 26, Issue 5 B, 2006, Pages 3773-3779

  Kramm, Christof M ^a   Wagner, Sabine ^b   Van Gool, Stefan ^c   Schmid, Hansjörg ^d   Sträter, Ronald ^e   Gnekow, Astrid ^f   Rutkowski, Stefan ^g   Wolff, Johannes E A ^h,i  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f KLINIKUM AUGSBURG   (Germany)

^g UNIVERSITY OF WÜRZBURG   (Germany)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anaplastic astrocytoma; Glioblastoma; Malignant glioma; Neurosurgery; Survival; Tumor resection

Indexed keywords

ADOLESCENT; ADULT; CANCER SURGERY; CANCER SURVIVAL; CHILD; DATA BASE; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVIEW; UNIVARIATE ANALYSIS;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; SURVIVAL ANALYSIS;

EID: 33750687522     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Devaux BC, O'Fallon JR and Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78: 767-775, 1993.
2. Kowalczuk A, Macdonald RL, Amidei C et al: Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41: 1028-1036, 1997.
3. Keles GE, Anderson B and Berger MS: The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52: 371-379, 1999.
4. Lacroix M, Abi-Said D, Fourney DR et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95: 190-198, 2001.
5. Kreth FW, Warnke PC, Scheremet R et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 762-766, 1993.
6. Albright AL, Sposto R, Holmes E et al: Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors. Neurosurgery 47: 879-885, 2000.
7. Heideman RL, Kuttesch J Jr, Gajjar AJ et al: Supratentorial malignant gliomas in childhood: a single institution perspective. Cancer 80: 497-504, 1997.
8. Wisoff JH, Boyett JM, Berger MS et al: Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg 89: 52-59, 1998.
9. Campbell JW, Pollack IF, Martinez AJ et al: High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery 38: 258-264, 1996.
10. Finlay JL and Wisoff JH: The impact of extent of resection in the management of malignant gliomas of childhood. Childs Nerv Syst 15: 786-788, 1999.
11. Benesch M, Wagner S, Berthold F and Wolff JE: Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH). J Neurooncol 72: 179-183, 2005.
12. Wolff JE, Gnekow AK, Kortmann RD et al: Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94: 264-271, 2002.
13. Kortmann RD, Kuhl J, Timmermann B et al: Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46: 269-279, 2000.
14. Wolff JE, Molenkamp G, Westphal S et al: Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme. Cancer 89: 2131-2137, 2000.
15. Wolff JE, Wagner S, Sindichakis M et al: Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study. Anticancer Res 22: 3569-3572, 2002.
16. Wagner S, Erdlenbruch B, Langler A et al: Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology. Cancer 100: 1750-1757, 2004.
17. Sposto R, Ertel IJ, Jenkin RD et al: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7: 165-177, 1989.
18. Rickert CH, Strater R, Kaatsch P et al: Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 158: 1525-1532, 2001.
19. Pollack IF, Finkelstein SD, Woods J et al: Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346: 420-427, 2002.